Inspire Medical Systems, Inc.
HealthcareNYSE:INSP · New York Stock Exchange
+$0.26 today
Vol 0.86M · Avg 1.12M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $145.4M +171.8% | $53.5M +353.0% | -$21.2M +52.9% | -$44.9M -6.8% | -$42.0M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $14.0M +113.1% | $6.5M +130.1% | $2.8M -1.8% | $2.9M +45.7% | $2.0M | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | -$88.7M | $0 | $0 | $0 | $0 | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $0 -100.0% | $116.0M +40.7% | $82.5M | $0 | $0 | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | -$87.4M -131.7% | -$37.7M +7.5% | -$40.8M -2353.1% | $1.8M +126.4% | -$6.9M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | -$26.2M -908.2% | -$2.6M +91.4% | -$30.2M -11.8% | -$27.0M -192.3% | -$9.2M | $592.6M | $1.3B | $626.2M |
| Inventory | -$65.2M -41.0% | -$46.2M -110.2% | -$22.0M -511.6% | $5.3M +161.1% | -$8.8M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | -$3.7M -720.4% | $604.0K -93.5% | $9.3M -35.2% | $14.4M +200.4% | $4.8M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | $7.8M -26.1% | $10.5M +391.6% | $2.1M -76.6% | $9.1M +43.5% | $6.4M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $133.7M +1881.6% | -$7.5M -690.6% | $1.3M -97.5% | $51.7M +93.1% | $26.8M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | $117.0M -10.2% | $130.2M +428.3% | $24.7M +113.1% | $11.6M +157.5% | -$20.1M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$38.5M +1.6% | -$39.1M -65.6% | -$23.6M -159.8% | -$9.1M -94.9% | -$4.7M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | -$250.4M +40.2% | -$418.6M -48.7% | -$281.4M | $0 +100.0% | -$10.0M | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $310.4M -9.9% | $344.6M +3263.3% | $10.2M | $0 -100.0% | $43.8M | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $0 | $0 | $0 +100.0% | -$10.5M | $0 | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | $21.4M +119.0% | -$113.1M +61.6% | -$294.8M -1404.5% | -$19.6M -167.3% | $29.1M | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $0 | $0 | $0 +100.0% | -$24.5M | $0 | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $14.6M -47.4% | $27.8M -10.7% | $31.1M -88.0% | $259.6M +1636.8% | $14.9M | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | -$175.0M -133.4% | -$75.0M | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | -$23.0M -346.2% | -$5.2M +69.9% | -$17.2M -39802.3% | -$43.0K | $0 | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | -$183.4M -250.1% | -$52.4M -475.6% | $13.9M -94.1% | $235.1M +1472.6% | $14.9M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | -$310.0K -162.7% | -$118.0K -172.0% | $164.0K +118.7% | $75.0K +494.7% | -$19.0K | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | -$45.3M -28.1% | -$35.4M +86.2% | -$256.1M -212.7% | $227.1M +848.4% | $23.9M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | $78.5M -13.9% | $91.1M +8798.7% | $1.0M -58.6% | $2.5M +110.0% | -$24.8M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Brookdale Senior Living Inc.
NYSE:BKD
$3.21B
Integer Holdings Corporation
NYSE:ITGR
$3.09B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.40B
Premier, Inc.
PINC
$2.34B
89bio, Inc.
ETNB
$2.20B
LeMaitre Vascular, Inc.
NASDAQ:LMAT
$2.10B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.74B
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
$1.46B
Ardent Health Partners, LLC
NYSE:ARDT
$1.34B
Artivion, Inc.
NYSE:AORT
$975.72M
SEC Filings
Recent regulatory filings
No filings found.
Does INSP generate free cash flow?
Inspire Medical Systems, Inc. (INSP) generated $78.48M of free cash flow in fiscal 2025.
How much operating cash flow does INSP produce?
Operating cash flow was $116.98M, before capital expenditures of $38.50M.
Explore More
Continue the stock analysis
Jump to another research area for this company.